USD 2.44 billion Growth in Travel Vaccines Market Size with 42% of the contribution from North America

NEW YORK, Aug. 22, 2022 /PRNewswire/ — The latest market analysis report titled Travel Vaccines Market by Disease Type and Geography – Forecast and Analysis 2022-2026 has been recently added to Technavio’s catalog. The report analysts have categorized the global travel vaccines market as a part of the global pharmaceuticals market. Our report provides extensive information on the value chain analysis for the travel vaccines market, which vendors can leverage to gain a competitive advantage during the forecast period. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period. One of the key factors driving the global travel vaccines market growth is the increase in global travel and migration. In addition, changes in the demographic profile of travelers globally are one of the key travel vaccines market trends that are expected to impact the industry positively in the forecast period. However, the absence of coverage for travel vaccines in many health plans is expected to limit the market’s growth during the forecast period.

For market scope, value chain analysis, and key market dynamics, Read a FREE Sample

Travel Vaccines Market Segmentation Highlights

For more segment-based insights and regional opportunities, Request for Sample Report

• The travel vaccines market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market. The travel vaccines market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

• Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE are some of the major market participants.

• To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

• Vendors are offering a wide range of offerings to gain a competitive edge in the market. For instance, CSL Ltd. offers the broadest influenza vaccine and a wide range of vaccines and specialty medicines that meet unique, local public health needs. Bharat Biotech Ltd. offers travel vaccines such as BioHib, a lyophilized vaccine that is used for development based on an Indian strain.

• Backed with competitive intelligence and benchmarking, our research reports on the travel vaccines market are designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.

Story continues

More vendor offerings and their strategic initiatives are available in this PDF Sample Report

Travel Vaccines Market Scope

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. Our travel vaccines market report covers the following areas:

Travel Vaccines Market Highlights

• CAGR of the market during the forecast period 2022-2026

• Detailed information on factors that will assist travel vaccines market growth during the next five years

• Estimation of the travel vaccines market size and its contribution to the parent market

• Predictions on upcoming trends and changes in consumer behavior

• The growth of the travel vaccines market

• Analysis of the market’s competitive landscape and detailed information on vendors

• Comprehensive details of factors that will challenge the growth of travel vaccines market vendors

Related Reports:

Vaccines Market by Type and Geography – Forecast and Analysis 2022-2026

Human Combination Vaccines Market by Type and Geography – Forecast and Analysis 2021-2025

Therapeutic Vaccines Market by Type and Geography – Forecast and Analysis 2020-2024

Foot and Mouth Disease Vaccines Market by Product and Geography – Forecast and Analysis 2021-2025

Table Of Contents :

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Disease Type

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/usd-2-44-billion-growth-in-travel-vaccines-market-size-with-42-of-the-contribution-from-north-america—technavio-301609618.html

SOURCE Technavio